PURA and esophageal squamous cell carcinoma: A series of in vitro and in vivo functional assays demonstrated that by disturbing the MEST-PURA interaction, G699-0288 could suppress cancer invasion and metastasis without overt toxicity, suggesting the potential of developing G699-0288 as an anticancer agent against ESCC metastasis.